RNHD | Tuveson: Pancreatic Cancer Biology and Medicine
David Tuveson, MD, PhD, Roy J. Zuckerberg Professor of Cancer Research, Cancer Center Director, Cold Spring Harbor Laboratory
to
RNHD | Pecot: New Frontiers in RNA Structure and Therapeutics to Combat Cancer
Chad Pecot, PhD, Professor, Department of Medicine, Director, UNC RNA Discovery Center, Co-Leader, UNC Lineberger Cancer Therapeutics Program
to
RNHD | Palmer: The impact of patient heterogeneity and treatment sequence in combination cancer therapy
Adam Palmer, PhD, Assistant Professor, Department of Pharmacology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
to
RNHD | Feng: Deciphering the anti-oncogenic effect of oncoproteins
Gen-Sheng Feng, PhD, Senior Investigator and Director, Institute of Cancer Research, Shenzhen Bay Laboratory
to
RNHD | Tsvetanova: Specification of divergent signaling responses by GPCR localization
Nina Tsvetanova, PhD
to
RNHD | Sheltzer: Leveraging mischaracterized drugs to uncover new cancer vulnerabilities
Jason Sheltzer, PhD, Assistant Professor, Stanford Cancer Institute, Stanford University
to
RNHD | Tamir: Evaluating the convergence of signaling and metabolism in diet induced obesity
Tigist Tamir, PhD, Assistant Professor, Systems Metabolism and Signaling Lab, Departments: Biochemistry and Biophysics | Nutrition Computational Medicine Program, Lineberger Comprehensive Cancer Center, UNC School of Medicine
to
RNHD | Gu: Catching transcription factors for proteasomal degradation
Xin Gu, PhD, Assistant Professor, Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School
to
RNHD | Chan: Exploiting dysregulated ribosome homeostasis for cancer therapy
Edmond M. Chan, MD, Assistant Professor of Medicine at Columbia University Irving Medical Center
to
RNHD | Nuñez: Rewriting the human epigenome with CRISPR
James Nuñez, PhD, Assistant Professor, Department of Molecular and Cell Biology at the University of California, Berkeley
to